Brooke Daniel
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Breast Cancer Treatment Studies
Papers in ⓘ
- Oncology 14
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 9
- Colorectal Cancer Treatments and Studies 1
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 3
- Co-authors
- Denise A. Yardley (11 shared papers)John D. Hainsworth (6 shared papers)Cassie M. Lane (2 shared papers)Patrick J. Ward (2 shared papers)Janice F. Eakle (2 shared papers)Sara M. Tolaney (2 shared papers)Adam Brufsky (2 shared papers)Foluso O. Ademuyiwa (2 shared papers)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)Clinical Breast Cancer (4 papers)Breast Cancer Research and Treatment (3 papers)Community Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomPortugal
In The Last Decade
Brooke Daniel
17 papers receiving 192 citations
Peers
Comparison fields: 5 of 29
- Oncology 170
- Cancer Research 58
- Pulmonary and Respiratory Medicine 69
- Genetics 17
- Radiology, Nuclear Medicine and Imaging 33
Countries citing papers authored by Brooke Daniel
This map shows the geographic impact of Brooke Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brooke Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brooke Daniel more than expected).
Fields of papers citing papers by Brooke Daniel
This network shows the impact of papers produced by Brooke Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brooke Daniel. The network helps show where Brooke Daniel may publish in the future.
Co-authors
The 25 scholars most cited alongside Brooke Daniel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 47 | |
| 2 | 2016 | 33 | |
| 3 | 2016 | 29 | |
| 4 | 2021 | 18 | |
| 5 | 2010 | 17 | |
| 6 | 2015 | 9 | |
| 7 | 2016 | 8 | |
| 8 | 2013 | 6 | |
| 9 | 2020 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2015 | 5 | |
| 12 | 2014 | 4 | |
| 13 | 2005 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2023 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2013 | 1 |
About Brooke Daniel
Brooke Daniel is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 196 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (3 papers), Fibroblast Growth Factor Research (2 papers), Cancer and Skin Lesions (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (170 citations), Cancer Research (58 citations), Pulmonary and Respiratory Medicine (69 citations), Genetics (17 citations) and Radiology, Nuclear Medicine and Imaging (33 citations). Brooke Daniel has collaborated with scholars based in United States, United Kingdom and Portugal. Frequent co-authors include Denise A. Yardley, John D. Hainsworth, Cassie M. Lane, Patrick J. Ward, Janice F. Eakle, Sara M. Tolaney, Adam Brufsky, Foluso O. Ademuyiwa, Lisa A. Carey and Howard A. Burris. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Breast Cancer, Breast Cancer Research and Treatment and Community Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.